Name of this trial: RC48 G001 (SEAGEN) What type of cancer is this for? Locally advanced or metastatic Urothelial Carcinoma Who is this trial for? Patients locally advanced, unresectable, or metastatic urothelial carcinoma, including urothelial originating from the renal pelvis, ureters, bladder, or urethra. What biomarkers are involved? HER2 positive which will be centrally confirmed.
Phone: (800) 411-7999
